BioCryst Pharmaceuticals shares owned by Doliver Capital Advisors
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Doliver Capital Advisors
from 13F filings
Historical chart of Doliver Capital Advisors investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Doliver Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Doliver Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $412k | 81k | 5.08 |
| 2023-12-31 | $485k | 81k | 5.99 |
| 2023-09-30 | $574k | 81k | 7.08 |
| 2023-06-30 | $570k | 81k | 7.04 |
| 2023-03-31 | $676k | 81k | 8.34 |
| 2022-12-31 | $930k | 81k | 11.48 |
| 2022-09-30 | $1.0M | 81k | 12.60 |
| 2022-06-30 | $857k | 81k | 10.58 |
| 2022-03-31 | $1.3M | 81k | 16.26 |
| 2021-12-31 | $1.5M | 100k | 15.21 |
| 2021-09-30 | $1.4M | 100k | 14.37 |